Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Stockholders??? Equity

v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2023 $ 40 $ 1,232 $ 33,692,018 $ (29,839,841) $ 3,853,449
Balance (in Shares) at Dec. 31, 2023 39,810 1,232,333      
Shares issued for legal settlement $ 235 359,112 359,347
Shares issued for legal settlement (in Shares) 235,328      
Issuance of warrants in conjunction with convertible loans 973,200   973,200
Net loss (1,136,225) (1,136,225)
Shares issued as settlement of accounts payable $ 158 271,673 271,831
Shares issued as settlement of accounts payable (in Shares) 157,639      
Shares issued for vested restricted stock units $ 2 (2)
Shares issued for vested restricted stock units (in Shares) 1,667      
Shares issued for common stock placement $ 232 167,768 168,000
Shares issued for common stock placement (in Shares) 232,558      
Balance at Dec. 31, 2024 $ 40 $ 1,859 35,463,769 (30,976,066) 4,489,602
Balance (in Shares) at Dec. 31, 2024 39,810 1,859,525      
Shares issued for legal settlement $ 601 361,409 362,010
Shares issued for legal settlement (in Shares) 601,250      
Shares issued for conversion of convertible loans and interest $ 7,690 2,903,789 2,911,479
Shares issued for conversion of convertible loans and interest (in Shares) 7,690,059      
Issuance of warrants in conjunction with convertible loans 1,385,000 1,385,000
Shares issued for the exercise of warrants $ 5,676 1,816,353 1,822,029
Shares issued for the exercise of warrants (in Shares) 5,676,000      
Warrant modification 565,277 565,277
Stock based compensation 61,204 61,204
Net loss (4,444,109) (4,444,109)
Balance at Dec. 31, 2025 $ 40 $ 15,826 $ 42,556,801 $ (35,420,175) $ 7,152,492
Balance (in Shares) at Dec. 31, 2025 39,810 15,826,834